Extracellular vesicles analysis for cancer diagnostics and pathology

I offer integrated expertise in EV isolation, characterization, and functional assessment using advanced biochemical, imaging, and lipidomic approaches. My group develops and applies 3D cancer models, including spheroids and patient-derived organoids, to study EV-mediated communication, biomarker discovery, and tumor-microenvironment interactions. We have access to clinical samples and established workflows for EV profiling, lipidomics, and mechanistic assays.

I am seeking partners for upcoming Horizon Europe Cancer Mission calls, particularly those focusing on translational biomarker development and precision oncology. I am also interested in collaborating with teams working on AI-assisted omics analysis, EV-based diagnostics, or computational integration of multi-layer clinical datasets.